Luke Sergott
Stock Analyst at Barclays
(3.36)
# 1,009
Out of 5,116 analysts
370
Total ratings
50.9%
Success rate
2.51%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Overweight | $625 → $650 | $578.61 | +12.34% | 30 | Jan 30, 2026 | |
| TWST Twist Bioscience | Maintains: Overweight | $37 → $39 | $41.07 | -5.04% | 20 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Overweight | $105 → $115 | $108.80 | +5.70% | 12 | Dec 15, 2025 | |
| QGEN Qiagen | Maintains: Overweight | $50 → $52 | $53.67 | -2.40% | 3 | Dec 15, 2025 | |
| RGEN Repligen | Maintains: Overweight | $175 → $200 | $149.37 | +33.90% | 4 | Dec 15, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Equal-Weight | $1.5 → $2 | $2.26 | -11.50% | 6 | Dec 15, 2025 | |
| NTRA Natera | Maintains: Overweight | $230 → $270 | $231.14 | +16.81% | 6 | Dec 15, 2025 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,600 → $1,550 | $1,373.24 | +12.87% | 4 | Dec 15, 2025 | |
| MEDP Medpace Holdings | Maintains: Underweight | $485 → $525 | $582.48 | -9.87% | 5 | Dec 15, 2025 | |
| ILMN Illumina | Maintains: Underweight | $100 → $110 | $144.81 | -24.04% | 22 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $185 → $200 | $180.25 | +10.96% | 23 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $120 | $114.04 | +5.23% | 6 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $215 | $210.48 | +2.15% | 11 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $13 | $8.79 | +47.90% | 20 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $55 | $44.29 | +24.18% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $22 | $20.20 | +8.91% | 15 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $10 → $15 | $16.81 | -10.77% | 14 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $165 | $133.85 | +23.27% | 14 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 → $105 | $102.34 | +2.60% | 9 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $20 | $18.12 | +10.38% | 23 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $15 → $12 | $10.92 | +9.89% | 27 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $325 | $231.12 | +40.62% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $225 → $250 | $218.89 | +14.21% | 41 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $185 → $200 | $230.15 | -13.10% | 24 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $100.07 | -10.06% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $370.72 | -5.59% | 18 | Apr 10, 2025 |
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Overweight
Price Target: $625 → $650
Current: $578.61
Upside: +12.34%
Twist Bioscience
Dec 15, 2025
Maintains: Overweight
Price Target: $37 → $39
Current: $41.07
Upside: -5.04%
Revvity
Dec 15, 2025
Maintains: Overweight
Price Target: $105 → $115
Current: $108.80
Upside: +5.70%
Qiagen
Dec 15, 2025
Maintains: Overweight
Price Target: $50 → $52
Current: $53.67
Upside: -2.40%
Repligen
Dec 15, 2025
Maintains: Overweight
Price Target: $175 → $200
Current: $149.37
Upside: +33.90%
Pacific Biosciences of California
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $1.5 → $2
Current: $2.26
Upside: -11.50%
Natera
Dec 15, 2025
Maintains: Overweight
Price Target: $230 → $270
Current: $231.14
Upside: +16.81%
Mettler-Toledo International
Dec 15, 2025
Maintains: Overweight
Price Target: $1,600 → $1,550
Current: $1,373.24
Upside: +12.87%
Medpace Holdings
Dec 15, 2025
Maintains: Underweight
Price Target: $485 → $525
Current: $582.48
Upside: -9.87%
Illumina
Dec 15, 2025
Maintains: Underweight
Price Target: $100 → $110
Current: $144.81
Upside: -24.04%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $185 → $200
Current: $180.25
Upside: +10.96%
Dec 15, 2025
Maintains: Overweight
Price Target: $85 → $120
Current: $114.04
Upside: +5.23%
Dec 15, 2025
Maintains: Overweight
Price Target: $210 → $215
Current: $210.48
Upside: +2.15%
Dec 15, 2025
Maintains: Overweight
Price Target: $14 → $13
Current: $8.79
Upside: +47.90%
Dec 15, 2025
Maintains: Overweight
Price Target: $45 → $55
Current: $44.29
Upside: +24.18%
Dec 15, 2025
Maintains: Overweight
Price Target: $17 → $22
Current: $20.20
Upside: +8.91%
Dec 15, 2025
Upgrades: Equal-Weight
Price Target: $10 → $15
Current: $16.81
Upside: -10.77%
Dec 15, 2025
Upgrades: Overweight
Price Target: $165
Current: $133.85
Upside: +23.27%
Nov 21, 2025
Downgrades: Equal-Weight
Price Target: $77 → $105
Current: $102.34
Upside: +2.60%
Nov 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $18.12
Upside: +10.38%
Oct 30, 2025
Downgrades: Equal-Weight
Price Target: $15 → $12
Current: $10.92
Upside: +9.89%
Oct 27, 2025
Maintains: Equal-Weight
Price Target: $275 → $325
Current: $231.12
Upside: +40.62%
Oct 22, 2025
Maintains: Overweight
Price Target: $225 → $250
Current: $218.89
Upside: +14.21%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $185 → $200
Current: $230.15
Upside: -13.10%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $100.07
Upside: -10.06%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $370.72
Upside: -5.59%